New progression in the treatment of retinoblastoma

International Journal of Ophthalmology

Volumn 9, Issue 1, 2009, Pages 139-141

  Zhao, Cheng ^a   You, Zhi Peng ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Progression; Retinoblastoma; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; RETINOBLASTOMA PROTEIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOTHERAPY; DISEASE COURSE; ENUCLEATION; EYE CANCER; FEMALE; GENE MUTATION; GENE THERAPY; HUMAN; HYPERTHERMIC THERAPY; INFANT; LASER COAGULATION; LEUKOKORIA; PATHOGENESIS; PHOTODYNAMIC THERAPY; PROGNOSIS; RETINOBLASTOMA; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 59849124091     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-5123.2009.01.047     Document Type: Review

References (26)

1. Rodriguez-Galindo C, Chantada GL, Haik BG, et al. Treatment of retinoblastoma: current status and future perspectives. Curr Treat Options Neurol 2007;9(4):294-307
2. Munier FL, Verwey J, Pica A, et al. New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques. Clin Experiment Ophthalmol 2008;36(1):78-89
3. Sahgal A, Millar BA, Michaels H, et al. Focal stereotactic external beam radiotherapy as a vision-sparing method for the treatment of peripapillary and perimacular retinoblastoma: preliminary results. Clin Oncol 2006;18(8):628-634
4. Higgins PD, Gerbi BJ, Macedon M, et al. Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma. J Appl Clin Med Phys 2006;7(2):9-17
5. Reisner ML, Viégas CM, Grazziotin RZ, et al. Retinoblastoma - comparative analysis of external radiotherapy techniques, including an IMRT technique. Int J Radiat Oncol Biol Phys 2007;67(3):933-941
6. Zhou LJ, Xiao XY, Wu KL, et al. Expression of EMMPRIN, MMPs and TIMP2 in retinoblastoma and normal retinal tissue. Int J Ophthalmol (Guoji Yanke Zazhi) 2008;8(6):1079-1082
7. Schueler AO, Flühs D, Anastassiou G, et al. Beta-ray brachytherapy with 106Ru plaques for retinoblastoma. Int J Radiat Oncol Biol Phys 2006;65(4):1212-1221
8. Antoneli CB, Ribeiro KB, Rodriguez-Galindo C, et al. The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J Pediatr Hematol Oncol 2007;29(10):700-704
9. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115(8): 1398-1404
10. Poulaki V, Mitsiades CS, Kotoula V, et al. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. Invest Ophthalmol Vis Sci 2007;48(10):4706-4719
11. Gorlick RG, Abramson DH, Sowers R, et al. Impairments in antifolate transport are common in retinoblastoma tumor samples. Pediatr Blood Cancer 2008;50(3):573-576
12. Kim JH, Kim JH, Yu YS, et al. Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma. Oncol Rep 2007;18 (6):1373-1377
13. Li Y, Tang LS, Zhou QH, et al. Application of suface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of retinoblastoma. Int J Ophthalmol (Guoji Yanke Zazhi) 2008;8(1):1-15
14. Tsui JY, Dalgard C, Van Quill KR, et al. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci 2008;49(2):490-496
15. Venè R, Arena G, Poggi A, et al. Novel cell death pathways induced by N-(4-hydroxyphenyl) retinamide: therapeutic implications. Mol Cancer Ther 2007;6(1):286-298
16. Boutrid H, Jockovich ME, Murray TG, et al. Targeting hypoxia, a novel treatment for advanced retinoblastoma. Invest Ophthalmol Vis Sci 2008;49(7):2799-2805
17. Shah HR, Conway RM, Van Quill KR, et al. Beta-lapachone inhibits proliferation and induces apoptosis in retinoblastoma cell lines. Eye 2008;22(3):454-460
18. Schefler AC, Cicciarelli N, Feuer W, et al. Macular retinoblastoma: evaluation of tumor control, local complications and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology 2007;114(1):162-169
19. Ruiz-Galindo E, Arenas-Huertero F, Ramón-Gallegos E. Expression of genes involved in heme biosynthesis in the human retinoblastoma cell lines WERI-Rb-1 and Y79: implications for photodynamic therapy. J Exp Clin Cancer Res 2007;26(2):195-200
20. McDaid C, Hartley S, Bagnall AM, et al. Systematic review of effectiveness of different treatments for childhood retinoblastoma. Health Technol Assess 2005;9(48):1-145
21. Chévez-Barrios P, Chintagumpala M, Mieler W, et al. Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol 2005;23 (31):7927-7935
22. Jia RB, Zhang P, Zhou YX, et al. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma. Ophthalmic Res 2007;39(2):108-115
23. Jia RB, Fan XQ, Wang XL, et al. Inhibition of VEGF expression by plasmid-based RNA interference in the retinoblastoma cells. Zhonghua Yan Ke Za Zhi 2007;43(6):493-498
24. Adachi M, Brooks SE, Stein MR, et al. Destruction of human retinoblastoma after treatment by the E variant of encephalomyocarditis virus. J Neurooncol 2006;77(3):233-240
25. Wadhwa L, Hurwitz MY, Chévez-Barrios P, et al. Treatment of invasive retinoblastoma in a murine model using an oncolytic picornavirus. Cancer Res 2007;67(22):10653-10656
26. Elison JR, Cobrinik D, Claros N, et al. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells. Arch Ophthalmol 2006;124(9):1269-1275